Iterated bootstrap procedure in individual bioequivalence

Year 2019, Volume: 68 Issue: 1, 583 - 594, 01.02.2019

Ufuk Beyaztas

https://doi.org/10.31801/cfsuasmas.438407

Abstract

In this paper, we propose an iterating principle in the bootstrap method to assess the individual bioequivalence under 2×4 randomized crossover design. The finite sample properties of the proposed algorithm are illustrated by an extensive simulation study and a real-world example. Our findings reveal that the proposed idea have better performance than the classical percentile bootstrap confidence limits.

Keywords

Bioequivalence, bootstrap, hypothesis testing

References

• Beran, R., Prepivoting to reduce level error of confidence sets, Biometrika (1987), 74, 151-173.
• DiCiccio, T. J. and Romano, J. P., A Review of Bootstrap Confidence Intervals, Journal of The Royal Statistical Society Series B-statistical Methodology (1998), 50, 338-354.
• FDA, In vivo bioequivalence studies based on population and individual bioequivalence approaches, Guidance for Industry, Rockville, MD: Center for Drug Evaluation and Research, Food and Drug Administration, 1997.
• FDA, Guidance for industry: Bioavaibility and bioequivalence studies for orally administered drug products: General Consideration, Rockville, MD: Center for Drug Evaluation and Research, Food and Drug Administration, 2003.
• Hall, P. On the bootstrap and confidence intervals, Annals of Statistics (1986), 54, 1431-1452.
• Hall, P. and Martin, M. A., On bootstrap resampling and iteration, Biometrika (1988), 75, 661-671.
• Hauschke, D., Steinijans, V., Pigeot, I., Bioequivalence studies in drug development, John Willey & Sons, 2007.
• Jones, B. and Kenward, M. G., Design and analysis of cross-over trials, Chapman & Hall/CRC, 2003.
• Martin, M. A., On bootstrap iteration for coverage correction in confidence intervals, Journal of the American Statistical Association (1990), 85, 1105--1118.
• Pigeot, I., The bootstrap percentile in Food and Drug Administration Regulations for bioequivalence assessment, Drug Information Journal (2001), 35, 1445-1453.
• Pigeot, I., Hauschke, D. and Shao, J., The bootstrap in bioequivalence studies, Journal of Biopharmaceutical Statistics (2011), 21, 1126-1139.
• Schall, R. and Luus, H. G., On population and individual bioequivalence, Statistics in Medicine (1993), 12, 1109-1124.
• Schall, R., Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar, Biometrics (1995), 54, 615-626.
• Schall, R. and Williams, R. L., Towards a practical strategy for assessing individual bioequivalence, Journal of Pharmacokinetics and Biopharmaceutics (1996), 24, 133-149.
• Senn, S. J., Cross-over trials in clinical research, John Willey, 1993.
• Shao, J., Chow, S. C. and Wang, B., The bootstrap procedure in individual bioequivalence, Statistics in Medicine (2000), 19, 2741-2754.
• Shao, J., Kubler, J. and Pigeot, I., Consistency of the Bootstrap Procedure in Individual Bioequivalence, Biometrika (2000), 87, 573-585.